Recruiting at 1 site No phase Smoking Cessation

Clinical trial for Smoking Cessation

Official title PASCAL Feasibility Study

ClinicalTrials.gov ID: NCT07301151

What this study is testing

What it's testing
The study wants to see if the chatbot is acceptable to people who want to quit smoking and to gather early data on how well it works.
Who it's for
People who are trying to quit smoking.
What's involved
Participants may receive a chatbot that talks with them about quitting smoking, while others will not get the chatbot. They will share their experiences and answer questions.
Time commitment
The study lasts a short period, with a few visits or check‑ins to discuss progress and give feedback.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 and older

You may be able to join if

  • Identify as Black or African American
  • Be at least 21 years of age
  • Meet a minimum smoking amount
  • Be willing to make a quit attempt in the next 30 days
  • Have a smartphone capable of downloading and running the study app

You likely can't join if

  • Medicinal nicotine use would require careful monitoring by a healthcare professional
  • Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking...
  • Are pregnant or breastfeeding
See the full eligibility criteria
Who can join
  • Identify as Black or African American
  • Be at least 21 years of age
  • Meet a minimum smoking amount
  • Be willing to make a quit attempt in the next 30 days
  • Have a smartphone capable of downloading and running the study app
  • Be able to upload data from the app
  • Agree to receive text message reminders about study activities
  • Be a native English speaker
  • Reside in Minnesota.
What rules you out
  • Medicinal nicotine use would require careful monitoring by a healthcare professional
  • Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior
  • Are pregnant or breastfeeding

The study team makes the final eligibility decision.

Where it is enrolling

  • Minneapolis, Minnesota, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Minneapolis, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.